Interleukin 4 and interleukin 13 downregulate the lipopolysaccharide-mediated inflammatory response by human gestation-associated tissues

Biology of Reproduction

Volumn 96, Issue 3, 2017, Pages 576-586

  Bryant, Aled H ^a   Spencer Harty, Samantha ^b   Owens, Siân Eleri ^a   Jones, Ruth H ^a   Thornton, Catherine A ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b ABERTAWE BRO MORGANNWG UNIVERSITY HEALTH BOARD   (United Kingdom)

Author keywords

IL13; IL4; Inflammation; Placenta; Pregnancy

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR ALPHA; LIPOPOLYSACCHARIDE; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PROSTAGLANDIN;

AMNION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DOWN REGULATION; EX VIVO STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; PLACENTA; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA EXTRACTION;

EID: 85022334259     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.116.145680     Document Type: Article

References (47)

1. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008; 371:75-84.
2. Bryant AH, Thornton CA. Cytokines and the Innate Immune Response at the Materno-Fetal Interface. Rijeka, Croatia. INTECH Open Access Publisher; 2012.
3. MacIntyre DA, Sykes L, Teoh TG, Bennett PR. Prevention of preterm labour via the modulation of inflammatory pathways. J Matern Fetal Neonatal Med 2012; 25(suppl 1):17-20.
4. Rivera DL, Olister SM, Liu X, Thompson JH, Zhang XJ, Pennline K, Azuero R, Clark DA, Miller MJ. Interleukin-10 attenuates experimental fetal growth restriction and demise. FASEB J 1998; 12:189-197.
5. Terrone DA, Rinehart BK, Granger JP, Barrilleaux PS, Martin JN, Jr, Bennett WA. Interleukin-10 administration and bacterial endotoxininduced preterm birth in a rat model. Obstet Gynecol 2001; 98:476-480.
6. BayraktarM, Peltier M, Vetrano A, Arita Y, Gurzenda E, Joseph A, Kazzaz J, Sharma S, Hanna N. IL10 modulates placental responses to tlr ligands. Am J Reprod Immunol 2009; 62:390-399.
7. Brown NL, Alvi SA, Elder MG, Bennett PR, Sullivan MH. The regulation of prostaglandin output from term intact fetal membranes by antiinflammatory cytokines. Immunology 2000; 99:124-133.
8. Herbert JM, Savi P, Laplace MC, Lale A. IL4 inhibits lps-, il-1 betaand tnf alpha-induced expression of tissue factor in endothelial cells and monocytes. FEBS Lett 1992; 310:31-33.
9. Berkman N, John M, Roesems G, Jose P, Barnes PJ, Chung KF. Interleukin 13 inhibits macrophage inflammatory protein-1 alpha production from human alveolar macrophages and monocytes. Am J Respir Cell Mol Biol 1996; 15:382-389.
10. Standiford TJ, Kunkel SL, Liebler JM, Burdick MD, Gilbert AR, Strieter RM. Gene expression of macrophage inflammatory protein-1 alpha from human blood monocytes and alveolar macrophages is inhibited by interleukin-4. Am J Respir Cell Mol Biol 1993; 9:192-198.
11. Essner R, Rhoades K,McBrideWH, MortonDL, Economou JS. IL4 downregulates il-1 and tnf gene expression in human monocytes. J Immunol 1989; 142:3857-3861.
12. Jiang H, Harris MB, Rothman P. IL4/IL13 signaling beyond jak/stat. J Allergy Clin Immunol 2000; 105:1063-1070.
13. Andrews AL, Holloway JW, Holgate ST, Davies DE. IL4 receptor alpha is an important modulator of IL4 and IL13 receptor binding: Implications for the development of therapeutic targets. J Immunol 2006; 176:7456- 7461.
14. Andrews AL, Nasir T, Bucchieri F, Holloway JW, Holgate ST, Davies DE. IL13 receptor alpha 2: a regulator of IL13 and IL4 signal transduction in primary human fibroblasts. J Allergy Clin Immunol 2006; 118:858-865.
15. Ouyang W, Ranganath SH, Weindel K, Bhattacharya D, Murphy TL, Sha WC, Murphy KM. Inhibition of th1 development mediated by gata-3 through an IL4-independent mechanism. Immunity 1998; 9:745-755.
16. Whitehead RP, Lew D, Flanigan RC, Weiss GR, Roy V, Glode ML, Dakhil SR, Crawford ED. Phase ii trial of recombinant human interleukin-4 in patients with advanced renal cell carcinoma: a southwest oncology group study. J Immunother 2002; 25:352-358.
17. Kiyota T, Okuyama S, Swan RJ, Jacobsen MT, Gendelman HE, Ikezu T. Cns expression of anti-inflammatory cytokine interleukin-4 attenuates alzheimer's disease-like pathogenesis in app+ps1 bigenic mice. FASEB J 2010; 24:3093-3102.
18. Horsfall AC, Butler DM, Marinova L, Warden PJ, Williams RO, Maini RN, Feldmann M. Suppression of collagen-induced arthritis by continuous administration of IL4. J Immunol 1997; 159:5687-5696.
19. Martin R. Interleukin 4 treatment of psoriasis: Are pleiotropic cytokines suitable therapies for autoimmune diseases? Trends Pharmacol Sci 2003; 24:613-616.
20. Patni S, Wynen LP, Seager AL, Morgan G, White JO, Thornton CA. Expression and activity of toll-like receptors 1-9 in the human term placenta and changes associated with labor at term. Biol Reprod 2009; 80:243- 248.
21. Patni S, Bryant AH, Wynen LP, Seager AL, Morgan G, Thornton CA. Functional activity but not gene expression of toll-like receptors is decreased in the preterm versus term human placenta. Placenta 2015; 36:1031-1038.
22. Laporte JC, Moore PE, Baraldo S, Jouvin MH, Church TL, Schwartzman IN, Panettieri RA, Jr, Kinet JP, Shore SA. Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. Am J Respir Crit Care Med 2001; 164:141-148.
23. Niemand C, Nimmesgern A, Haan S, Fischer P, Schaper F, Rossaint R, Heinrich PC, Müller-Newen G. Activation of stat3 by IL6 and IL10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3. J Immunol 2003; 170:3263-3272.
24. Popov N, Schulein C, Jaenicke LA, Eilers M. Ubiquitylation of the amino terminus of myc by scf(beta-trcp) antagonizes scf(fbw7)-mediated turnover. Nat Cell Biol 2010; 12:973-981.
25. Fedorak RN, Gangl A, Elson CO, Rutgeerts P, Schreiber S, Wild G, Hanauer SB, Kilian A, Cohard M, LeBeaut A, Feagan B. Recombinant human interleukin 10 in the treatment of patients with mild to moderately active crohn's disease. The interleukin 10 inflammatory bowel disease cooperative study group. Gastroenterology 2000; 119:1473-1482.
26. Wei LH, Yang Y, Wu G, Ignarro LJ. IL4 and IL13 upregulate ornithine decarboxylase expression by pi3k and map kinase pathways in vascular smooth muscle cells. Am J Physiol Cell Physiol 2008; 294:C1198-C1205.
27. Namgaladze D, Snodgrass RG, Angioni C, Grossmann N, Dehne N, Geisslinger G, Brune B. AMP-activated protein kinase suppresses arachidonate 15-lipoxygenase expression in interleukin-4-polarized human macrophages. J Biol Chem 2015; 290:24484-24494.
28. Lim R, Barker G, Lappas M. Activation of ampk in human fetal membranes alleviates infection-induced expression of pro-inflammatory and pro-labour mediators. Placenta 2015; 36:454-462.
29. Mueller T, Terada T, Rosenberg IM, Shibolet O, Podolsky DK. Th2 cytokines down-regulate tlr expression and function in human intestinal epithelial cells. J Immunol 2006; 176:5805-5814.
30. Reece P, Gauvreau GM, Sehmi R, Denburg JA. IL4 and IL13 differentially regulate tlr-induced eosinophil-basophil differentiation of cord blood cd34+ progenitor cells. PLoS One 2014; 9:e100734.
31. Chambers M, Kirkpatrick G, Evans M, Gorski G, Foster S, Borghaei RC. IL4 inhibition of il-1 induced matrix metalloproteinase-3 (mmp-3) expression in human fibroblasts involves decreased ap-1 activation via negative crosstalk involving of jun n-terminal kinase (jnk). Exp Cell Res 2013; 319:1398-1408.
32. Hwang I, Yang J, Hong S, Ju Lee E, Lee SH, Fernandes-Alnemri T, Alnemri ES, Yu JW. Non-transcriptional regulation of nlrp3 inflammasome signaling by IL4. Immunol Cell Biol 2015; 93:591-599.
33. Fichtner-Feigl S, StroberW, Kawakami K, Puri RK, Kitani A. IL13 signaling through the IL13alpha2 receptor is involved in induction of tgf-beta1 production and fibrosis. Nat Med 2006; 12:99-106.
34. Andrews AL, Nordgren IK, Kirby I, Holloway JW, Holgate ST, Davies DE, Tavassoli A. Cytoplasmic tail of IL13ralpha2 regulates IL4 signal transduction. Biochem Soc Trans 2009; 37:873-876.
35. Naka T, Fujimoto M, Tsutsui H, Yoshimura A. Negative regulation of cytokine and tlr signalings by socs and others. Adv Immunol 2005; 87:61- 122.
36. Vannier E, Miller LC, Dinarello CA. Coordinated antiinflammatory effects of interleukin 4: Interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. Proc Natl Acad Sci USA 1992; 89:4076-4080.
37. de Oliveira Gomes A, de Oliveira Silva DA, Silva NM, de Freitas Barbosa B, Franco PS, Angeloni MB, Fermino ML, Roque-Barreira MC, Bechi N, Paulesu LR, dos Santos MC, Mineo JR, Ferro EAV. Effect of macrophage migration inhibitory factor (mif) in human placental explants infected with toxoplasma gondii depends on gestational age. Am J Pathol 2011; 178:2792-2801.
38. Peltier MR. Immunology of term and preterm labor. Reprod Biol Endocrinol 2003; 1:122.
39. Ng PY, Ireland DJ, Keelan JA. Drugs to block cytokine signaling for the prevention and treatment of inflammation induced preterm birth. Front Immunol 2015; 6: 166.
40. Chatterjee P, Chiasson VL, Bounds KR, Mitchell BM. Regulation of the anti-inflammatory cytokines interleukin-4 and interleukin-10 during pregnancy. Front Immunol 2014; 5:253.
41. Dinarello CA. Induction of interleukin-1 and interleukin-1 receptor antagonist. Semin Oncol 1997; 24:S9-81-S89-93.
42. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest 2000; 117:1162-1172.
43. Curtale G, Mirolo M, Renzi TA, Rossato M, Bazzoni F, Locati M. Negative regulation of toll-like receptor 4 signaling by IL10-dependent microrna-146b. Proc Natl Acad Sci USA 2013; 110:11499-11504.
44. Sykes L, MacIntyre DA, Yap XJ, Teoh TG, Bennett PR. The th1:Th2 dichotomy of pregnancy and preterm labour. Mediators Inflamm 2012; 2012:967629.
45. Dudley DJ, Hunter C, Varner MW, Mitchell MD. Elevation of amniotic fluid interleukin-4 concentrations in women with preterm labor and chorioamnionitis. Am J Perinatol 1996; 13:443-447.
46. Gotsch F, Romero R, Kusanovic JP, Erez O, Espinoza J, Kim CJ, Vaisbuch E, Than NG, Mazaki-Tovi S, Chaiworapongsa T, Mazor M, Yoon BH et al. The anti-inflammatory limb of the immune response in preterm labor, intra-amniotic infection/inflammation, and spontaneous parturition at term: a role for interleukin-10. J Matern Fetal Neonatal Med 2008; 21:529-547.
47. Klementiev B, EnevoldsenMN, Li S, Carlsson R, Liu Y, Issazadeh-Navikas S, Bock E, Berezin V. Antiinflammatory properties of a peptide derived from interleukin-4. Cytokine 2013; 64:112-121.